Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05594381 |
|---|---|
| Brief Title: | A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. |
| First Submitted : | September 29, 2022 |
| First Submitted that Met QC Criteria : | October 21, 2022 |
| First Posted : | October 26, 2022 |
| Last Update Submitted that Met QC Criteria : | October 21, 2022 |
| Last Update Posted : | October 26, 2022 |